Skip Navigation LinksHome > February 2014 - Volume 63 - Issue 2 > Cardiac Stem Cell Therapy: Review of the Native Cardiac Prog...
Journal of Cardiovascular Pharmacology:
doi: 10.1097/FJC.0b013e318299ebc0
Invited Review Article

Cardiac Stem Cell Therapy: Review of the Native Cardiac Progenitor Cells and Future Direction

Ye, Jianqin MD, PhD*; Yeghiazarians, Yerem MD*,†,‡

Collapse Box

Abstract

Various stem cell types have been tested for regenerating damaged myocardium after myocardial infarction. However, the results of clinical trials have not been consistent, with only some of the trials reporting small improvements in cardiac function. It seems that engraftment and survival of injected cells is limited and transplanted stem cells either do not differentiate into cardiac cells or differentiate into only limited number of cardiac cells. The exact mechanism(s) of cardiac functional improvement by cell therapy are unclear, but paracrine effect may play a central role. The resident cardiac progenitor cells identified within the adult myocardium have distinct advantages over other stem cell types for cardiac cell therapy, as they are likely precommitted to the cardiovascular fate. However, isolating and expanding these cells from cardiac biopsies is a challenge. More recently, direct reprogramming of fibroblasts into cardiomyocytes has given new hope for myocardial regeneration. Here we will review different stem cells used in cardiac cell therapy with a focus on the native cardiac progenitor cells and briefly outline future directions of cardiac cell therapy.

Copyright © 2013 by Lippincott Williams & Wilkins

Follow Us!

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.